Pain Research and Treatment / 2014 / Article / Tab 2

Clinical Study

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain

Table 2

Baseline to follow-up scores.

BaselineFollowup value

VAS score
NPSI total score : 0.025*
(i) Burning : 0.063
(ii) Pressing : 0.073
(iii) Paroxysmal pain : 0.061
(iv) Evoked pain : 0.279
(v) Paresthesia/dysesthesia : 0.003*
EQ-5D score

A significant improvement was observed in the VAS and NPSI scores between baseline and followup. Moreover, the NPSI subscores showed a highly significant improvement for the paresthesia/dysesthesia subscore and a trend towards amelioration for the other subscores.
VAS: Visual Analogue Scale; NPSI: Neuropathic Pain Symptom Inventory; EQ-5D: health questionnaire five dimensions.
Indicates the statistical significance ( value < 0.05).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.